AU2006250765A1 - Injectable compositions and process for preparation of such compositions - Google Patents

Injectable compositions and process for preparation of such compositions Download PDF

Info

Publication number
AU2006250765A1
AU2006250765A1 AU2006250765A AU2006250765A AU2006250765A1 AU 2006250765 A1 AU2006250765 A1 AU 2006250765A1 AU 2006250765 A AU2006250765 A AU 2006250765A AU 2006250765 A AU2006250765 A AU 2006250765A AU 2006250765 A1 AU2006250765 A1 AU 2006250765A1
Authority
AU
Australia
Prior art keywords
composition according
cox
solution
mixture
continuous stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006250765A
Other languages
English (en)
Inventor
Sanjay Boldhane
Rajesh Jain
Kour Chand Jindal
Sukhjeet Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AU2006250765A1 publication Critical patent/AU2006250765A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2006250765A 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions Abandoned AU2006250765A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27
IN1357/DEL/2005 2005-05-27
PCT/IN2006/000177 WO2006126214A2 (en) 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions

Publications (1)

Publication Number Publication Date
AU2006250765A1 true AU2006250765A1 (en) 2006-11-30

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006250765A Abandoned AU2006250765A1 (en) 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions

Country Status (15)

Country Link
EP (1) EP1895983A2 (de)
JP (1) JP2008542260A (de)
KR (1) KR20080016689A (de)
CN (1) CN101217939A (de)
AU (1) AU2006250765A1 (de)
BR (1) BRPI0611170A2 (de)
CA (1) CA2609242A1 (de)
CR (1) CR9616A (de)
EA (1) EA200702646A1 (de)
MX (1) MX2007014862A (de)
NO (1) NO20076468L (de)
RS (1) RS20070461A (de)
TN (1) TNSN07482A1 (de)
WO (1) WO2006126214A2 (de)
ZA (1) ZA200711068B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010538092A (ja) 2007-09-07 2010-12-09 ユナイテッド セラピューティクス コーポレーション グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法
EP3417708B1 (de) 2009-03-12 2020-06-17 Cumberland Pharmaceuticals, Inc. Verabreichung von intravenösem ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (zh) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102370615B (zh) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
CN103889414A (zh) 2011-10-18 2014-06-25 拉夸里亚创药株式会社 药物组合物
CN102512383A (zh) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 供注射用的帕瑞昔布钠药物组合物
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (zh) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
US20140187635A1 (en) * 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
TWI646091B (zh) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103263385B (zh) * 2013-05-17 2016-04-27 江苏正大清江制药有限公司 一种塞来昔布长效纳米注射剂及其制备方法
MA40599A1 (fr) * 2014-12-20 2017-11-30 Troikaa Pharmaceuticals Ltd Formulations injectables de paracétamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
CN107303266B (zh) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN107303264A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 无泡沫左旋奥拉西坦注射液及其制备方法
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN111103381A (zh) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 一种液质联用测定人血浆中尼美舒利浓度的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
IN187306B (de) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
US7695736B2 (en) * 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Also Published As

Publication number Publication date
NO20076468L (no) 2008-02-27
MX2007014862A (es) 2008-02-21
CN101217939A (zh) 2008-07-09
KR20080016689A (ko) 2008-02-21
TNSN07482A1 (fr) 2009-03-17
EA200702646A1 (ru) 2008-06-30
EP1895983A2 (de) 2008-03-12
JP2008542260A (ja) 2008-11-27
WO2006126214A2 (en) 2006-11-30
CA2609242A1 (en) 2006-11-30
CR9616A (es) 2008-10-30
ZA200711068B (en) 2009-03-25
WO2006126214A3 (en) 2007-06-07
RS20070461A (en) 2008-11-28
BRPI0611170A2 (pt) 2010-08-17

Similar Documents

Publication Publication Date Title
AU2006250765A1 (en) Injectable compositions and process for preparation of such compositions
AU2003261274B2 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
EP2938325B1 (de) Diclofenaczusammensetzung
CN107810000B (zh) 来氟米林的可注射药物组合物
KR101383941B1 (ko) 피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
WO2011014541A1 (en) Stable formulations of azacitidine
US11730815B2 (en) Stable liquid pharmaceutical compositions comprising bendamustine
CA2596031C (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts
KR101924786B1 (ko) 이부프로펜의 주사용 약제학적 조성물
MXPA02009336A (es) Solucion parenteral que contiene amiodarona.
WO2016005995A2 (en) Glycol free stable liquid compositions of bendamustine
JP2013529675A (ja) パラセタモールを含む医薬組成物およびその製造法
EP1002531A1 (de) Wassermischbare Arzneizusammensetzung von nicht-steroiden entzündungshemmenden Arzneimitteln
JPH11302197A (ja) ヒアルロン酸安定化組成物
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
US9211251B2 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
JPH05139955A (ja) 安定な点眼剤
WO2019130228A1 (en) Stable liquid compositions of melphalan
EP4134083A1 (de) Pharmazeutische zusammensetzungen von bortezomib
EP1508332A1 (de) Medizinische zusammensetzung
WO2004039360A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
EP1228757B1 (de) Stabile pharmazeutische Nimesulidverbindungen
TW202245791A (zh) 醫藥配方

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period